Skip to content

John Bennett



Image of John Bennett
John Bennett



John is a partner in the Intellectual Property practice in the Boston Office who focuses on representing innovators in the life science industry. He has nearly 20 years of first-chair trial experience in high-stakes intellectual property and technology disputes. John’s experience includes numerous trial representations in cases brought under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act as well as trade secret, licensing and contract disputes. Clients praise John for his “unique understanding of the interplay between IP, regulatory, and business issues in the pharmaceutical sector” and regularly turn to him for advice regarding patents, exclusivities and litigation risk concerning commercial and late-stage clinical assets.

John’s engagements have included trial representation before various federal courts and the Patent Trial and Appeal Board, appellate representation before the Federal Circuit and other courts of appeal. His experience includes work on numerous patent and trade secret cases involving a variety of technologies including pharmaceuticals, biotechnology, medical devices, telecommunications and internet content delivery systems. John also is frequently asked to conduct diligence, render opinions and perform freedom to operate analyses.

John actively engages in pro bono work, including appearing as lead counsel in federal litigation against the U.S. Government, which led to the release of Francisco Rodriguez-Guardado, a longtime Massachusetts Institute of Technology custodian and father of three U.S. citizen children, who was suddenly incarcerated and threatened with deportation in 2017-2018.

Experience highlights

Related articles


Publications: 26 January 2023

New Protecting American intellectual Property Act authorizes sanctions for trade secret theft

On January 5, 2023, President Joe Biden signed into law the Protecting American Intellectual Property Act of 2022 (PAIP). PAIP requires that the President identify to Congress individuals and entities…

Read more

Publications: 08 September 2022

Life Sciences Webinar Series | CREATES Act: What we've learned so far and recommendations for the industry

Read more

Publications: 09 June 2022

Webinar: "Reverse Payments" from Actavis to California AB 824: The Current State of Litigation Settlements in the Hatch-Waxman/BCPIA Space

Read more

News: 25 February 2022

Allen & Overy expanding life sciences intellectual property litigation practice with five new U.S. partners and launching in Boston

Read more



Intellectual Property


Life Sciences



One Beacon Street
MA 02108

View office →



Admitted to the Bar of the State of Massachusetts, 2001

U.S. Court of Appeals for the Federal Circuit

U.S. Court of Appeals for the First Circuit

U.S. Court of Appeals for the Fifth Circuit

U.S. Court of Appeals for the Tenth Circuit

U.S. District Court for the District of Massachusetts


JD, Boston College Law School, 2000

B.A., Dartmouth College, cum laude with high honors, B.A., 1996